49%
Decrease in Cardiovascular Disease Deaths in
High Risk Women with Vitamin E
JAMA , July 2005
In the July 2005 journal
of the American Medical Association, known as JAMA, there was a study
published called the Women’s Health Study. This study revealed the
results of the largest and longest vitamin E trial in history.
The study consisted
of:
• |
39,876 apparently
healthy US women aged 45 years and over. |
• |
Women were
randomly assigned either esterified vitamin E, placebo, or aspirin
or placebo. |
• |
Women were
followed for 10 years. The results showed that vitamin E use resulted
in a significant 24% reduction in all cardiovascular events. |
• |
Women 65
years or over comprised 10% of the study subjects, but contributed
31% of the end points. |
• |
Women 65 years or older
are at highest risk for CVD. |
Why is this important? Women
in the highest risk percentile for Cardiovascular Disease (women age
65 and over) saw a 34% decrease in heart attacks and an incredible
49% decrease in Cardiovascular deaths.
These results are even more
dramatic when you realize that the women were only taking 600 I.U.of
esterified alpha tocopheryl every other day!
Results Not Covered,
Just Covered Up
Amazingly, the authors of the study somehow concluded that vitamin
E had no benefit. And the resulting headlines were, "Study finds
vitamin E has no benefit in women." "Vitamin E fails again."
The fantastic results seen in highest-risk women were not only hidden
by the authors of the study, they managed to marginalize the significant
24% decrease in CVD events in all women, to conclude that vitamin
E had no benefit—a conclusion that contradicted their findings.
Like clockwork, the fact
that aspirin had no benefit seemed to evade the researchers and the
media.
| DISCLAIMER:
The information in this article is for educational purposes
only, and is not intended to provide medical advice which should
always be obtained from a qualified health practitioner, and
has not been approved by the U.S. Food and Drug Administration. |
